Clinical Trial Update: Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin, capecitabine, and radiation therapy with or without cetuximab in patients undergoing surgery for high-risk rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN